These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model. Pestieau SR; Stuart OA; Sugarbaker PH Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617 [TBL] [Abstract][Full Text] [Related]
26. The acute toxicity of dimethylamides in several animal species. Wiles JS; Narcisse JK Am Ind Hyg Assoc J; 1971 Aug; 32(8):539-45. PubMed ID: 5140424 [No Abstract] [Full Text] [Related]
27. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma. Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832 [TBL] [Abstract][Full Text] [Related]
28. [Activation of ifosfamide in man and animal]. Brock N; Hoefer-Janker H; Hohorst HJ; Scheef W; Schneider B; Wolf HC Arzneimittelforschung; 1973 Jan; 23(1):1-14. PubMed ID: 4353374 [No Abstract] [Full Text] [Related]
29. [Disaccharidases in the small intestine mucosa during cytostatic therapy]. Hartwich G; Domschke W; Matzkies F; Pesch HJ Verh Dtsch Ges Inn Med; 1974; 80():1697-9. PubMed ID: 4375898 [No Abstract] [Full Text] [Related]
31. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center. Chan A; Leow YC; Sim MH J Oncol Pharm Pract; 2009 Sep; 15(3):161-5. PubMed ID: 19171555 [TBL] [Abstract][Full Text] [Related]
32. Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice. Auletta AE; Gery AM; Mead JA Cancer Res; 1974 Jul; 34(7):1581-5. PubMed ID: 4833911 [No Abstract] [Full Text] [Related]
33. [The results of attack polychemotherapy in broncho-pleuro-pulmonary cancer. Phytohemagglutinin in the prevention and treatment of hematologic complications of antimitotics]. Brocard H; Akoun G Poumon Coeur; 1968; 24(1):33-8. PubMed ID: 5652205 [No Abstract] [Full Text] [Related]
34. [Blastolysin, an agent potentiating the antitumor action of ionizing radiation]. Iarmonenko SP; Syrkin AB; Treshchalin ID Dokl Akad Nauk SSSR; 1980; 253(6):1495-9. PubMed ID: 7428605 [No Abstract] [Full Text] [Related]
36. [Verify the optimum administration of anticancer agent--cisplatin]. Miyanaga N; Akaza H Gan To Kagaku Ryoho; 2001 Oct; 28(10):1339-44. PubMed ID: 11681239 [TBL] [Abstract][Full Text] [Related]
37. Total tumor cell count and hematopoietic system of ah 109A-bearing rats treated with mitomycin C and carboquone. Himori T; Ujiie S; Mimata Y; Sugiyama Z; Wakui A Sci Rep Res Inst Tohoku Univ Med; 1982 Dec; 29(1-4):77-86. PubMed ID: 6308758 [No Abstract] [Full Text] [Related]
38. Investigations into the lymphopaenic and immunosuppressive properties of the antitumour agent, mitoclomine. Fox M; Rees RW; Bennett DH; Henry L Lymphology; 1971 Jun; 4(2):35-47. PubMed ID: 5089346 [No Abstract] [Full Text] [Related]
39. Combination effects of SC144 and cytotoxic anticancer agents. Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats. Chen J; Ping Q; Guo J; Chu X; Song M Biopharm Drug Dispos; 2006 Mar; 27(2):53-9. PubMed ID: 16299828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]